Sialic Acid Blockade Suppresses Tumor Growth by Enhancing T-cell-Mediated Tumor Immunity

Area of Science:

• Immunology
• Cancer Biology
• Glycobiology

Background:

• Sialic acids on cancer cells create an immunosuppressive tumor microenvironment, hindering antitumor immunity and promoting immune evasion.
• Current understanding of sialic acid's role in modulating antitumor responses and effective therapeutic strategies remains limited.

Purpose of the Study:

• To investigate the therapeutic potential of blocking sialic acid expression in cancer.
• To elucidate the mechanisms by which sialic acid blockade impacts the tumor immune microenvironment and antitumor immunity.

Main Methods:

• Intratumoral injection of a sialic acid mimetic (Ac53F-axNeu5Ac) to block sialic acid expression in vivo.
• Analysis of tumor immune cell composition, including natural killer cells, CD8+ T-cells, regulatory T-cells, and myeloid regulatory cells.
• Assessment of CD8+ T-cell-mediated cytotoxicity and synergy with adoptive T-cell transfer and CpG adjuvant therapy.

Main Results:

• Sialic acid blockade suppressed tumor growth across multiple models and significantly altered tumor immune cell composition.
• Increased infiltration of natural killer cells and CD8+ T-cells, alongside decreased regulatory T-cells and myeloid regulatory cells, was observed.
• Enhanced CD8+ T-cell-mediated tumor cell killing, improved synergy with immunotherapy, and increased dendritic cell activation were demonstrated.

Conclusions:

• Sialic acids play a critical role in tumor immune evasion by modulating the immunosuppressive tumor microenvironment.
• Sialic acid blockade represents a viable strategy to create an immune-permissive environment, promoting CD8+ T-cell-mediated antitumor immunity.
• This approach shows promise as a monotherapy or in combination with other immune-based interventions for cancer treatment.